Cargando…

Outcome of a de-labelling algorithm compared with results of penicillin (β-lactam) allergy testing

BACKGROUND: Penicillin allergy labels frequently impede guideline-directed treatment with a penicillin or other β-lactam antibiotics. Despite presumed allergy, targeted questioning may indicate a low probability of sensitization and permit reasonably safe administration of the antibiotic in question...

Descripción completa

Detalles Bibliográficos
Autores principales: Schrüfer, Philipp, Stoevesandt, Johanna, Trautmann, Axel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8941741/
https://www.ncbi.nlm.nih.gov/pubmed/35317861
http://dx.doi.org/10.1186/s13223-022-00659-1
_version_ 1784673165220249600
author Schrüfer, Philipp
Stoevesandt, Johanna
Trautmann, Axel
author_facet Schrüfer, Philipp
Stoevesandt, Johanna
Trautmann, Axel
author_sort Schrüfer, Philipp
collection PubMed
description BACKGROUND: Penicillin allergy labels frequently impede guideline-directed treatment with a penicillin or other β-lactam antibiotics. Despite presumed allergy, targeted questioning may indicate a low probability of sensitization and permit reasonably safe administration of the antibiotic in question. In this study, we evaluated a standardized algorithm aiming to differentiate non-allergic patients from those with true allergic β-lactam hypersensitivity. METHODS: We retrospectively applied a de-labelling algorithm in 800 consecutive patients with suspected β-lactam hypersensitivity. All had undergone complete allergy work-up permitting to definitely exclude or diagnose β-lactam allergy between 2009 and 2019. RESULTS: In 595 (74.4%) out of 800 cases evaluated, β-lactam allergy could be excluded by negative challenge testing. IgE-mediated anaphylaxis was diagnosed in 70 (8.7%) patients, delayed-type hypersensitivity in 135 (16.9%). In 62 (88.6%) anaphylaxis cases, the algorithm correctly advised to use an alternative antibiotic. Accuracy was higher in patients with moderate to severe anaphylaxis (97.7%) compared to those with a history of mild reactions (73.1%). The algorithm correctly identified 122 (90.4%) patients with proven delayed-type hypersensitivity. It permitted de-labelling in 330 (55.5%) out of 595 patients with diagnostic exclusion of penicillin hypersensitivity, but failed to identify the remaining 265 (44.5%) as low-risk cases. CONCLUSIONS: The algorithm detected 89.8% of cases with penicillin (β-lactam) allergy, sensitivity was optimal for moderate to severe anaphylaxis. Study data justify the implementation of a standardized de-labelling algorithm under close supervision in order to permit guideline-directed treatment and reduce the use of broad-spectrum antibiotics as part of an antibiotic stewardship program. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13223-022-00659-1.
format Online
Article
Text
id pubmed-8941741
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-89417412022-03-24 Outcome of a de-labelling algorithm compared with results of penicillin (β-lactam) allergy testing Schrüfer, Philipp Stoevesandt, Johanna Trautmann, Axel Allergy Asthma Clin Immunol Research BACKGROUND: Penicillin allergy labels frequently impede guideline-directed treatment with a penicillin or other β-lactam antibiotics. Despite presumed allergy, targeted questioning may indicate a low probability of sensitization and permit reasonably safe administration of the antibiotic in question. In this study, we evaluated a standardized algorithm aiming to differentiate non-allergic patients from those with true allergic β-lactam hypersensitivity. METHODS: We retrospectively applied a de-labelling algorithm in 800 consecutive patients with suspected β-lactam hypersensitivity. All had undergone complete allergy work-up permitting to definitely exclude or diagnose β-lactam allergy between 2009 and 2019. RESULTS: In 595 (74.4%) out of 800 cases evaluated, β-lactam allergy could be excluded by negative challenge testing. IgE-mediated anaphylaxis was diagnosed in 70 (8.7%) patients, delayed-type hypersensitivity in 135 (16.9%). In 62 (88.6%) anaphylaxis cases, the algorithm correctly advised to use an alternative antibiotic. Accuracy was higher in patients with moderate to severe anaphylaxis (97.7%) compared to those with a history of mild reactions (73.1%). The algorithm correctly identified 122 (90.4%) patients with proven delayed-type hypersensitivity. It permitted de-labelling in 330 (55.5%) out of 595 patients with diagnostic exclusion of penicillin hypersensitivity, but failed to identify the remaining 265 (44.5%) as low-risk cases. CONCLUSIONS: The algorithm detected 89.8% of cases with penicillin (β-lactam) allergy, sensitivity was optimal for moderate to severe anaphylaxis. Study data justify the implementation of a standardized de-labelling algorithm under close supervision in order to permit guideline-directed treatment and reduce the use of broad-spectrum antibiotics as part of an antibiotic stewardship program. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13223-022-00659-1. BioMed Central 2022-03-22 /pmc/articles/PMC8941741/ /pubmed/35317861 http://dx.doi.org/10.1186/s13223-022-00659-1 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Schrüfer, Philipp
Stoevesandt, Johanna
Trautmann, Axel
Outcome of a de-labelling algorithm compared with results of penicillin (β-lactam) allergy testing
title Outcome of a de-labelling algorithm compared with results of penicillin (β-lactam) allergy testing
title_full Outcome of a de-labelling algorithm compared with results of penicillin (β-lactam) allergy testing
title_fullStr Outcome of a de-labelling algorithm compared with results of penicillin (β-lactam) allergy testing
title_full_unstemmed Outcome of a de-labelling algorithm compared with results of penicillin (β-lactam) allergy testing
title_short Outcome of a de-labelling algorithm compared with results of penicillin (β-lactam) allergy testing
title_sort outcome of a de-labelling algorithm compared with results of penicillin (β-lactam) allergy testing
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8941741/
https://www.ncbi.nlm.nih.gov/pubmed/35317861
http://dx.doi.org/10.1186/s13223-022-00659-1
work_keys_str_mv AT schruferphilipp outcomeofadelabellingalgorithmcomparedwithresultsofpenicillinblactamallergytesting
AT stoevesandtjohanna outcomeofadelabellingalgorithmcomparedwithresultsofpenicillinblactamallergytesting
AT trautmannaxel outcomeofadelabellingalgorithmcomparedwithresultsofpenicillinblactamallergytesting